5 Best Dividend Achievers to Buy According to Hedge Funds

3. Johnson & Johnson (NYSE: JNJ)

Number of Hedge Fund Holders: 81
Dividend Yield: 2.46%
Number of Years of Consistent Dividend Growth: 59

Johnson & Johnson (NYSE: JNJ) is next on our list of the best dividend achievers to buy according to hedge funds and ranks 3rd. It is another medical company based in the US and works to develop medical devices, pharmaceuticals, and other consumer packaged goods.

Cantor Fitzgerald’s Louise Chen has an Overweight rating and a $200 price target on Johnson & Johnson (NYSE: JNJ) shares as of this June.

In the second quarter of 2021, Johnson & Johnson (NYSE: JNJ) had an EPS of $2.48, beating estimates by $0.20. The company’s revenue was $23.31 billion up 27.14% year over year and beating estimates by $802.29 million. Johnson & Johnson (NYSE: JNJ) has also gained 2.07% in the past 6 months and 10.33% year to date.

By the end of the first quarter of 2021, 81 hedge funds out of the 866 tracked by Insider Monkey held stakes in Johnson & Johnson (NYSE: JNJ) worth roughly $6.91 billion. This is compared to 81 hedge funds in the previous quarter with a total stake value of approximately $5.82 billion.